pyrazines has been researched along with ovalbumin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Davies, GE; Evans, DP | 1 |
| Barnette, M; Grous, M | 1 |
| Li, HL; Wang, WJ; Wang, XH; Yang, L | 1 |
| Bai, M; Fang, ZY; Feng, G; Tao, XN; Xiong, L | 1 |
| Cascio, P; Cenci, S; Cerruti, F; Mariani, E; Oliva, L; Pasqualetto, E; Sitia, R | 1 |
| Amann, K; Kalden, JR; Manz, RA; Maseda, D; Meister, S; Moser, K; Neubert, K; Voll, RE; Weisel, F; Wiethe, C; Winkler, TH | 1 |
| Nader, MA | 1 |
| El-Agamy, DS; El-Awady, MS; Nader, MA; Shalaby, AA | 1 |
| Cheng, H; Huang, M; Ji, NF; Wang, H; Xie, YC; Yin, KS; Zhang, MS; Zhao, X | 1 |
| Dong, J; Du, X; Li, M; Liu, F; Liu, J; Luo, Q; Sun, J; Wei, K; Wei, Y; Xu, F; Zhang, H | 1 |
| Li, Z; Tong, J; Wang, Y; Zhu, H | 1 |
11 other study(ies) available for pyrazines and ovalbumin
| Article | Year |
|---|---|
Studies with two new phosphodiesterase inhibitors (ICI 58, 301 and ICI 63, 197) on anaphylaxis in guinea pigs, mice and rats.
Topics: Acetamides; Anaphylaxis; Animals; Cyclic AMP; Freund's Adjuvant; Germ-Free Life; Guinea Pigs; Immune Sera; Immunoglobulin E; Lung; Mice; Ovalbumin; Passive Cutaneous Anaphylaxis; Pertussis Vaccine; Phosphodiesterase Inhibitors; Precipitins; Pyrazines; Pyrimidines; Rats; Triazoles | 1973 |
Prevention by phosphodiesterase inhibitors of antigen-induced contraction of guinea-pig colonic smooth muscle.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Antigens; Colon; Cyclic Nucleotide Phosphodiesterases, Type 4; Guinea Pigs; Immunization; Male; Muscle Contraction; Muscle, Smooth; Ovalbumin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Purinones; Pyrazines; Pyrrolidinones; Rolipram | 1994 |
[Effect of ligustrazine on airway remodeling in asthmatic rats].
Topics: Animals; Anti-Asthmatic Agents; Asthma; Collagen Type III; Disease Models, Animal; Drugs, Chinese Herbal; Immunohistochemistry; Male; Muscle, Smooth, Vascular; Ovalbumin; Pyrazines; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 2004 |
Effect and mechanism of ligustrazine on Th1/Th2 cytokines in a rat asthma model.
Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Eosinophils; GATA3 Transcription Factor; Interferon-gamma; Interleukin-4; Lung; Male; Ovalbumin; Pyrazines; Rats; T-Box Domain Proteins; Th1 Cells; Th2 Cells | 2007 |
Dampening Ab responses using proteasome inhibitors following in vivo B cell activation.
Topics: Animals; Antibody Formation; Antibody-Producing Cells; Apoptosis; B-Lymphocytes; Boronic Acids; Bortezomib; Cell Differentiation; Immunoglobulin M; Immunoglobulin mu-Chains; Lipopolysaccharides; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Ovalbumin; Protease Inhibitors; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Spleen | 2008 |
The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis.
Topics: Animals; Boronic Acids; Bortezomib; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Mice, Inbred MRL lpr; Mice, Inbred NZB; Models, Immunological; Nephritis; Ovalbumin; Plasma Cells; Protease Inhibitors; Proteasome Inhibitors; Pyrazines; Time Factors | 2008 |
Inhibition of anaphylaxis like reaction and mast cell activation by Sitagliptin.
Topics: Anaphylaxis; Animals; Cytokines; Dose-Response Relationship, Drug; Histamine Release; Hypersensitivity; Immunoglobulin E; Male; Mast Cells; Mice; Ovalbumin; p-Methoxy-N-methylphenethylamine; Passive Cutaneous Anaphylaxis; Pyrazines; Rats; Rats, Wistar; Sitagliptin Phosphate; Triazoles; Tumor Necrosis Factor-alpha | 2011 |
Sitagliptin exerts anti-inflammatory and anti-allergic effects in ovalbumin-induced murine model of allergic airway disease.
Topics: Animals; Anti-Allergic Agents; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Cytokines; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Inflammation; Lung; Male; Mice; Nitric Oxide Synthase Type II; Ovalbumin; Pyrazines; RNA, Messenger; Sitagliptin Phosphate; Triazoles | 2012 |
Ligustrazine corrects Th1/Th2 and Treg/Th17 imbalance in a mouse asthma model.
Topics: Animals; Asthma; Cells, Cultured; Cytokines; Disease Models, Animal; Drugs, Chinese Herbal; Eosinophils; Female; Gene Expression Regulation; Homeostasis; Humans; Mice; Mice, Inbred C57BL; Neutrophils; Ovalbumin; Pyrazines; T-Lymphocytes, Regulatory; Th1-Th2 Balance; Th17 Cells; Transcription Factors | 2014 |
Ligustrazine attenuates inflammation and the associated chemokines and receptors in ovalbumine-induced mouse asthma model.
Topics: Animals; Anti-Asthmatic Agents; Asthma; Bronchoalveolar Lavage Fluid; Chemokines; Disease Models, Animal; Female; Interleukins; Lung; MAP Kinase Signaling System; Mice, Inbred BALB C; Ovalbumin; Pyrazines; Receptors, CCR7; STAT3 Transcription Factor | 2016 |
Ligustrazine Inhibits Lung Phosphodiesterase Activity in a Rat Model of Allergic Asthma.
Topics: Airway Resistance; Allergens; Animals; Asthma; Bronchoalveolar Lavage Fluid; Computational Biology; Disease Models, Animal; Immunoglobulin E; Lung; Male; Ovalbumin; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Rats; Rats, Sprague-Dawley; Respiratory Hypersensitivity; RNA, Messenger | 2022 |